ArticleInternational journal of women's health2025
Contraceptive Utilization and Lived Experiences of Women with Rheumatic Heart Disease Attending Uganda Heart Institute and Mbarara Regional Referral Hospital.
Article in International journal of women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Women with rheumatic heart disease (RHD) face high risks during pregnancy due to hemodynamic stress and teratogenic medications. Appropriate contraceptive use is therefore critical, yet little is known about utilization patterns and lived experiences among this population in Uganda. Methods: We conducted a mixed-methods study at Uganda Heart Institute and Mbarara Regional Referral Hospital. A cross-sectional survey of 84 women with RHD assessed contraceptive use, while in-depth interviews with 13 participants explored lived experiences. Quantitative data were analyzed descriptively, and qualitative data thematically using Van Manen's existential framework. Results: Study found only 25 (29.7%) women reported using contraception, and 40% were using contra-indicated methods. Among those who discontinued, 34.6% cited side effects such as heavy bleeding, weight gain and palpitation. Notably, 69.6% of women on a teratogenic medication were not using contraception. Qualitative findings revealed themes of fear (of side effects and complications), communication gaps with health providers, hopelessness and frustration due to method failure, and ingenuity in coping strategies. These findings highlight limited counseling and high reliance on inappropriate methods, putting women at risk of unplanned and high-risk pregnancies. Conclusion: Contraceptive utilization among women with RHD in Uganda is low, inconsistent, and often involves unsafe methods. The absence of adequate counseling and reliance on contraindicated options underline the urgent need for multidisciplinary, guideline-based contraceptive counseling and support for women with RHD to prevent unplanned pregnancies and reduce maternal and fetal risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.